Anna Grimsrud, International AIDS Society
International AIDS Society
Presenter Of 5 Presentations
Reflects from the pre-record: It's time for differentiated PrEP delivery
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Wrap-up
Organizer
Bill & Melinda Gates Foundation; World Health Organization; International AIDS Society
Introduction
Organizer
International AIDS Society
20 minutes Q&A and wrap-up (Live)
Organizer
Bill and Melinda Gates Foundation; Georgetown University; IAS
Welcome and framing
Organizer
International AIDS Society
Moderator Of 3 Sessions
Bringing PrEP closer to home: Why is now the time for differentiated PrEP?
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Organizer
Bill and Melinda Gates Foundation; Georgetown University; IAS
Session Description
In ratifying the sustainable development goals (SDGs), United Nations Member States have pledged to achieve a series of ambitious health and development goals by 2030, including ending AIDS as a public health threat and achieving universal health coverage. In many low- and middle-income countries, these efforts are complementary. However, there are also areas of potential tension should either of the two responses make major decisions without regard for the other. For example, an increasingly targeted HIV response that misses potential opportunities for integration, or a UHC response that chooses not to include HIV in the UHC benefit package. Investing strategically in areas of convergence between the two responses is an important strategy for ensuring greater mutual benefit and progress for both the HIV and UHC agendas. The session will increase knowledge and engagement around potential opportunities for greater synergy between the HIV and UHC responses.
Presenter Of 1 Presentation
Key takeaways
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Moderator Of 1 Session
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Presenter Of 6 Presentations
Reflects from the pre-record: It's time for differentiated PrEP delivery
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Wrap-up
Organizer
Bill & Melinda Gates Foundation; World Health Organization; International AIDS Society
Introduction
Organizer
International AIDS Society
20 minutes Q&A and wrap-up (Live)
Organizer
Bill and Melinda Gates Foundation; Georgetown University; IAS
Key takeaways
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Welcome and framing
Organizer
International AIDS Society
Moderator Of 4 Sessions
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Bringing PrEP closer to home: Why is now the time for differentiated PrEP?
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Organizer
Bill and Melinda Gates Foundation; Georgetown University; IAS
Session Description
In ratifying the sustainable development goals (SDGs), United Nations Member States have pledged to achieve a series of ambitious health and development goals by 2030, including ending AIDS as a public health threat and achieving universal health coverage. In many low- and middle-income countries, these efforts are complementary. However, there are also areas of potential tension should either of the two responses make major decisions without regard for the other. For example, an increasingly targeted HIV response that misses potential opportunities for integration, or a UHC response that chooses not to include HIV in the UHC benefit package. Investing strategically in areas of convergence between the two responses is an important strategy for ensuring greater mutual benefit and progress for both the HIV and UHC agendas. The session will increase knowledge and engagement around potential opportunities for greater synergy between the HIV and UHC responses.